Gujarat Kidney And Super Speciality (GKSL) — deviation variation

1 deviation variation 🟡 Notable Neutral 📄 PDF

📢 Key Event
No deviation in IPO fund utilization for Q1 2026

💡 Investor Takeaway
Shareholders can be assured that capital deployment remains strictly on track with no regulatory or operational deviations.

Gujarat Kidney And Superspeciality Limited reported no deviation in the utilization of IPO proceeds for the quarter ended June 30, 2026, as confirmed by its Audit Committee on August 14, 2026. The filing details fund allocation across specific projects including hospital acquisitions and equipment purchases, with all expenditures aligned to approved objectives. No material changes or forward guidance were disclosed.

2 deviation variation 🟡 Notable Neutral 📄 PDF

📢 Key Event
Third monitoring report confirms proper utilization of ₹250.80 crore raised funds

🔄 What Changed
Corrected clerical errors in fund allocation via updated shareholder resolutions

🔮 What's Next
NA

💡 Investor Takeaway
Investors can be assured that raised funds are being used as disclosed for hospital expansion and acquisitions with no material deviations.

The third monitoring agency report confirms proper utilization of the ₹250.80 crore raised through a fresh equity issue, with all funds allocated to specific hospital acquisitions, expansion projects, and repayments as per the prospectus. No material deviations were observed, and the company has corrected earlier clerical errors in fund allocation through updated shareholder resolutions. The report validates compliance with SEBI regulations and confirms no conflicts of interest in the monitoring process.

📊 Stock Analysis — GKSL ✨ Ask AI About This

About Gujarat Kidney And Super Speciality Limited (GKSL)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹1,250.85 Cr P/E: 64.5 ROE: 64.5% ROCE: 77.4%

View full GKSL stock details →

📡 Get AI alerts when GKSL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GKSL — Free

💡 Ask AI about this filing

"How does the fund allocation compare to peer hospital chains?" "What is the expected ROI timeline for the new Vadodara facility?" "Are there any pending regulatory approvals for future acquisitions?"

Ask AI Free →

📊 More GKSL filings

See all GKSL filings →

🔥 Also filed on 14 August 2026

CEIGALL Ceigall India Limited Financial Results MAHAPEXLTD Maha Rashtra Apex Corporation Limited Corporate Action SAATVIKGL Saatvik Green Energy Limited Financial Results LIBAS Libas Consumer Products Limited Corporate Action GENUSPOWER Genus Power Infrastructures Limited Financial Results LUXIND Lux Industries Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GKSL files new disclosures

Track GKSL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GKSL — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd

Gujarat Kidney And Super Speciality Limited (GKSL) — deviation variation | 14 August 2026(2 announcements)

About Gujarat Kidney And Super Speciality Limited (GKSL)

📡 Get AI alerts when GKSL files next

💡 Ask AI about this filing

📊 More GKSL filings

🔥 Also filed on 14 August 2026